BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Hemophilia Alliance - ECPv6.3.7//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Hemophilia Alliance
X-ORIGINAL-URL:https://hemoalliance.org
X-WR-CALDESC:Events for Hemophilia Alliance
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20251211T140000
DTEND;TZID=America/New_York:20251211T150000
DTSTAMP:20260423T032858
CREATED:20251130T181451Z
LAST-MODIFIED:20251130T181451Z
UID:71858-1765461600-1765465200@hemoalliance.org
SUMMARY:🟥 Member Webinar : Hemophilia Alliance Hosts - A Webinar from CSL Behring - New! Real-World Evidence to Support Optimization of Factor IX Prophylaxis
DESCRIPTION:Date: Thursday\, December 11th\, 2025\nTime: 2:00pm – 3:00pm ET \n \n  \n  \n  \n  \n \nWEBINAR TITLE: \nNew! Real-World Evidence to Support Optimization of Factor IX Prophylaxis \nSUMMARY: \nThis webinar will discuss recent evidence on prophylactic treatment strategies for hemophilia B from a U.S. real-world retrospective analysis of factor IX products. The session will highlight factor consumption patterns\, bleeding outcomes\, and comparative effectiveness following a switch to inform clinical decision-making and optimize patient care. \nAUDIENCE: \nAll HTC Staff. \nSPEAKER: \n \nVidhi Desai\, Senior Medical Director (Coagulation)\, US Medical Affairs \nVidhi Desai joined CSL Behring in 2018 as Therapeutic Area Head\, Director Medical Affairs for Coagulation Products in North America\, providing strategic and tactical medical leadership for Hemgenix®\, Idelvion®\, Afstyla® and Humate-P®\, contributing to key operational and cross-functional projects as a member of the Medical Affairs leadership team. \nPrior to joining CSL Behring\, Vidhi worked as an attending hematologist at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell\, focusing primarily on benign hematologic disorders. \nVidhi earned her Doctor of Medicine at New York Medical College and completed her internal medicine and hematology/oncology training at Rutgers Robert Wood Johnson Medical School in New Brunswick\, NJ.
URL:https://hemoalliance.org/alliance-events/a-webinar-from-csl-behring-new-real-world-evidence-to-support-optimization-of-factor-ix-prophylaxis/
CATEGORIES:Members Only,Webinar
END:VEVENT
END:VCALENDAR